Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

The conglomerate received the top environmental, social, and governance honour from the television broadcaster.

This article is presented by EFPIA with the support of AbbVie I made a trip back to Europe recently, where I spent the vast majority of my pharmaceutical career, to share my perspectives on ...

A company that consistently pays and increases its dividends usually has a strong balance sheet, healthy cash flow, and a management team committed to shareholder returns, which are all indicators of ...

Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its 11 acute facilities and dozens of outpatient locations, enhancing patient safety and ...

The story of a cancer-fighting molecule that took half a century to build is really a story about how slow, stubborn ...

Mycosis fungoides is the most common subtype, making up the vast majority of CTCL cases. While early-stage disease has an estimated five-year survival rate of 88%, it remains a difficult-to-manage ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Lateral flow assays (LFAs) are point-of-care devices that are known for their ...